Sevelamer Carbonate Powder, For Suspension
Product Images NDC 33342-289

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 33342-289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

666 (Sevelamer Carbonate Suspension 2 4g 90s Cont)

666 (Sevelamer Carbonate Suspension 2 4g 90s Cont)
This is a description for a pharmaceutical product named Sevelamer Carbonate for Oral Suspension in citrus flavor. Each box contains 90 packets of the medication. The manufacturer is Macleods Pharmaceuticals Ltd. and the product is for Macleods Pharma USA, Inc. It is manufactured in Baddi, Himachal Pradesh, INDIA. The usual dosage is 2.4 of sevelamer carbonate. The medication packet includes inactive ingredients such as mannitol, ferric oxide yellow, povidone, xanthan gum, sodium chloride, sucralose, orange flavor, vanilla flavor, and lemon-lime flavor. The directions advise emptying a packet into 2 ounces of water, stir well and drink within 30 minutes. It is essential to store the medication at 20° to 25°C (68° to 77°F) and protect it from moisture.*
FDA Label Image

111 (Sevelamer Carbonate Suspension 8g 90s Cont)

111 (Sevelamer Carbonate Suspension 8g 90s Cont)
This text contains information about a medication called Sevelamer Carbonate for Oral Suspension in Citrus Flavor. Each packet contains 0.8g of sevelamer carbonate, along with various inactive ingredients. The medication is produced by Macleods Pharma and is stored at a temperature between 20°C to 25°C. Directions for use include emptying a packet into a cup with water and consuming it within 30 minutes. It is essential to keep the medication away from moisture and out of reach of children.*
FDA Label Image

Str (Sevelamer Figure 1)

Str (Sevelamer Figure 1)
FDA Label Image

Fig-2 (Sevelamer Figure 2)

Fig-2 (Sevelamer Figure 2)
FDA Label Image

Fig-1 (Sevelamer Figure 3)

Fig-1 (Sevelamer Figure 3)
This text provides information about a reduction in serum phosphorus levels. The data includes values related to active control, reduction from baseline, and reduction in serum phosphorus in mg/dL. It seems to be a measurement or evaluation related to a medical or scientific study.*
FDA Label Image

Fig-4 (Sevelamer Figure 4)

Fig-4 (Sevelamer Figure 4)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.